The services Panaxea offers include:

Health Technology Assessment

The process of bringing your healthcare innovation to the market is lengthy and complicated. Besides the clinical or humanistic value that your product generates, for example by decreasing complication rate, prolonging survival, improving patient flow, the economic value needs to be demonstrated to healthcare payers.

Using Health Technology Assessment, the value of a novel medical intervention is quantified by simultaneous analysis of effects on patient outcomes and total costs of care associated with the innovation in comparison to the standard of care. An objective measure of the medical innovation’s value is generally required for (national) reimbursement applications.


Health Services & Systems Research

Increasing and changing demands concerning the health of populations and limited resources require our health care organisations and systems to rethink their sustainability. To achieve objectives, such as improved healthcare quality, health outcomes, efficiency and staff satisfaction, we support our clients in making evidence-based decisions. With tailor-made research projects, we provide insights into what works, for whom, at what cost, and under what circumstances. Based on your challenge, we can support you by:

  • translating your challenge in a problem statement and evaluation design;
  • providing you with state-of-the-art insights and identifying where you can make a difference;
  • assessing the feasibility and value of your intervention or strategy;
  • assessing its implementation fidelity;
  • making evidence-based and practical recommendations;
  • present the findings to peer-reviewed journals and conferences.


Health Innovation Assessment Consultancy

If you want to objectively show the advantages and competitiveness of your healthcare innovation to potential investors, future users, payers (reimbursement) or even the media, you can greatly benefit from Panaxea’s Health Innovation Assessment Consultation (HIAC).

We help you prepare yourself for (future) discussions with stakeholders about your innovations. During a 1,5 h discussion, we advise you on how to collect, analyse and present data. HIAC takes into account true multi-stakeholder perspectives on value assessment, the realm of marketplace decision making, and the requirements for a robust assessment of your healthcare innovation.

Adding Evidence to Healthcare Innovation


  • Thermofisher Scientific / Phadia
    As a diagnostic company in the Dutch market we need to help out our customers to show what the added value of testing within allergy diagnosis is. Within this value is having a high standardized test a starting point, but showing addition to patient management and health economy, is essential for the patient, the customer, health insurance and our company. To achieve this we work together with Panaxea.
    Thermofisher Scientific / Phadia
  • Panaxea was a great partner for this project, due to their well organized and professional approach. We could rely that the project was carried out in time and met our expectations. We are looking forward to follow-up projects.
  • The people of Panaxea have a lot of expertise on HE modeling. They are very cooperative in finding solutions for challenges during the project. It was very nice working together.
  • Thermo Fisher Scientific (Henk Nijzing)
    Clear understanding of our needs, resulting in the development of a perfect, flexible model.
    Thermo Fisher Scientific (Henk Nijzing)
  • The outcome was more than expected and highly valued within our company.
  • The cooperation with Panaxea is an open atmosphere with room for discussion and mutual respect for each others opinions.
  • Extremely solid reliable work, based on own knowledge and flexibly integrating meaningful cumstomers' wishes - open minded collaboration, not making a quick project sell.

A selection of our Clients